Gene Editing Companies Enjoy Momentum While Gene Therapies Lag
September 30, 2021
Livshits, Geulah
Several Readouts on Allogeneic Cell Therapy Expected in 2020
March 20, 2020
Prasad, Raju
Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha
Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit
Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola
Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj
Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj
Interview with the Founder, Chairman and CEO: Cellectis S.A. (NASDAQ:CLLS)
October 21, 2016
Choulika, Andre
